Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.21 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.68.
Market Cap
9.21T
Revenue
4.67T
Profits
189.1B
PE Ratio
48.68
Profit Margin
4.05%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.04% | 4,549,953 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 650.65B | -0.09% | 16,428,385 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 466.45B | -0.02% | 8,176,607 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 362.35B | -0.19% | 31,159,667 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 338.30B | 0.45% | 8,616,226 | 450.53B |
| 6 | NVS | Novartis AG | 265.70B | -0.39% | 2,247,928 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 259.31B | -0.04% | 3,060,378 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 240.87B | -1.04% | 4,582,570 | 46.34B |
| 9 | AMGN | Amgen Inc. | 208.49B | 1.55% | 8,528,354 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 191.02B | 0.12% | 10,370,709 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 186.13B | -0.52% | 16,421,967 | 30.46B |
| 12 | ABT | Abbott Laboratories | 177.55B | 0.37% | 27,075,251 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.65B | 0.07% | 75,593,388 | 63.70B |
| 14 | DHR | Danaher Corporation | 148.90B | -0.32% | 8,835,010 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 138.95B | 2.55% | 4,930,005 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 128.84B | -1.55% | 2,434,833 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.81B | 0.35% | 36,849,553 | 49.19B |
| 18 | MDT | Medtronic plc | 117.85B | -0.69% | 15,446,269 | 37.54B |
| 19 | CVS | CVS Health Corporation | 113.62B | -1.58% | 21,880,292 | 412.65B |
| 20 | SYK | Stryker Corporation | 105.53B | -1.79% | 4,805,096 | 25.84B |
| 21 | MCK | McKesson Corporation | 101.98B | -0.56% | 2,707,476 | 410.98B |
| 22 | SNY | Sanofi | 101.74B | -1.53% | 2,244,770 | 55.89B |
| 23 | GSK | GSK plc | 100.62B | -1.65% | 4,709,244 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.60B | -0.31% | 5,445,311 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 89.12B | -0.80% | 2,076,303 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.37B | -0.58% | 2,473,437 | 15.53B |
| 27 | CI | The Cigna Group | 72.74B | -0.26% | 2,331,858 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 62.81B | -0.48% | 29,277,732 | 21.00B |
| 29 | ARGX | argenx SE | 62.49B | -0.55% | 244,023 | 5.32B |
| 30 | MRNA | Moderna, Inc. | 61.50B | -2.55% | 20,238,545 | 2.23B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.71B | -0.73% | 2,960,711 | 28.42B |
| 32 | COR | Cencora, Inc. | 58.92B | -0.20% | 3,344,626 | 332.77B |
| 33 | NTRA | Natera, Inc. | 53.25B | 0.84% | 3,718,176 | 2.71B |
| 34 | CAH | Cardinal Health, Inc. | 52.42B | -0.42% | 4,143,251 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 50.87B | 0.01% | 4,258,353 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.29B | -0.24% | 6,416,946 | 22.48B |
| 37 | HUM | Humana Inc. | 46.38B | 0.44% | 1,681,386 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.42B | -0.54% | 5,477,350 | 17.32B |
| 39 | A | Agilent Technologies, Inc. | 44.11B | 0.08% | 4,852,144 | 7.37B |
| 40 | IQV | IQVIA Holdings Inc. | 43.85B | -1.12% | 5,595,941 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 42.13B | -1.34% | 6,003,019 | 3.46B |
| 42 | MDLN | Medline Inc. | 41.60B | -1.49% | 19,953,959 | 29.94B |
| 43 | WAT | Waters Corporation | 41.42B | -1.88% | 1,035,742 | 4.64B |
| 44 | RVMD | Revolution Medicines, Inc. | 40.93B | -3.04% | 5,940,042 | - |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.31B | 1.02% | 1,124,664 | 4.55B |
| 46 | HLN | Haleon plc | 40.14B | -0.85% | 45,166,448 | 14.80B |
| 47 | ONC | BeOne Medicines AG | 39.89B | -0.74% | 438,382 | 6.13B |
| 48 | ILMN | Illumina, Inc. | 36.18B | -2.27% | 32,588,763 | 4.49B |
| 49 | DXCM | DexCom, Inc. | 33.72B | 1.61% | 14,576,638 | 4.97B |
| 50 | RPRX | Royalty Pharma plc | 33.59B | -0.88% | 7,104,695 | 2.54B |
| 51 | RMD | ResMed Inc. | 32.19B | -1.50% | 3,862,487 | 5.65B |
| 52 | CNC | Centene Corporation | 32.16B | -2.97% | 13,448,573 | 180.30B |
| 53 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.06B | -2.42% | 2,756,179 | 4.80B |
| 54 | BIIB | Biogen Inc. | 31.84B | -1.62% | 2,636,087 | 10.03B |
| 55 | ALC | Alcon Inc. | 31.50B | -0.21% | 3,461,430 | 10.86B |
| 56 | ZTS | Zoetis Inc. | 29.50B | -2.22% | 9,881,007 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.97B | -0.50% | 7,625,437 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.73B | -0.53% | 32,200,465 | 7.53M |
| 59 | MTD | Mettler-Toledo International Inc. | 27.90B | -1.28% | 544,545 | 4.13B |
| 60 | DGX | Quest Diagnostics Incorporated | 27.20B | -0.40% | 1,925,637 | 11.56B |
| 61 | INSM | Insmed Incorporated | 26.21B | -3.21% | 3,445,008 | 1.14B |
| 62 | LH | Labcorp Holdings Inc. | 26.01B | -0.63% | 1,738,510 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.50B | -1.17% | 1,457,547 | 3.33B |
| 64 | INCY | Incyte Corporation | 25.40B | -1.81% | 3,700,439 | 5.82B |
| 65 | PHG | Koninklijke Philips N.V. | 24.21B | - | 735,693 | 20.18B |
| 66 | BNTX | BioNTech SE | 24.13B | -2.64% | 1,195,346 | 3.03B |
| 67 | GH | Guardant Health, Inc. | 24.07B | -2.03% | 3,080,785 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.22B | -0.53% | 1,501,109 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.10B | 0.03% | 3,183,974 | 21.81B |
| 70 | GMAB | Genmab A/S | 20.72B | 0.58% | 2,711,563 | 4.13B |
| 71 | STE | STERIS plc | 19.99B | -1.44% | 1,544,123 | 6.04B |
| 72 | VTRS | Viatris Inc. | 19.47B | -1.05% | 15,646,116 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.19B | 1.18% | 3,947,389 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.09B | -0.46% | 522,197 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.01B | -2.24% | 3,321,775 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | -1.27% | 2,214,759 | 4.60B |
| 77 | ASND | Ascendis Pharma A/S | 15.55B | -0.97% | 1,558,774 | 1.20B |
| 78 | SOLV | Solventum Corporation | 15.12B | 1.50% | 2,318,212 | 8.31B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 14.86B | -3.69% | 2,816,258 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.46B | -0.22% | 5,243,437 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 14.24B | 0.73% | 13,060,581 | - |
| 82 | TEM | Tempus AI, Inc. | 14.05B | -3.14% | 9,321,156 | 1.43B |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.27B | -1.28% | 1,481,169 | 4.00B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.02B | -1.04% | 4,103,479 | 713.07M |
| 85 | HALO | Halozyme Therapeutics, Inc. | 12.76B | 2.53% | 10,183,862 | 1.66B |
| 86 | ICLR | ICON Public Limited Company | 12.66B | -3.28% | 1,122,557 | 8.29B |
| 87 | PEN | Penumbra, Inc. | 12.51B | -0.40% | 994,495 | 1.50B |
| 88 | BMRN | BioMarin Pharmaceutical Inc. | 12.38B | -1.75% | 4,455,959 | 3.41B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.28B | -0.54% | 330,618 | 1.28B |
| 90 | EHC | Encompass Health Corporation | 12.01B | -1.13% | 1,439,555 | 6.21B |
| 91 | CORT | Corcept Therapeutics Incorporated | 11.92B | -3.98% | 17,233,443 | 830.81M |
| 92 | BTSG | BrightSpring Health Services, Inc. | 11.83B | 0.32% | 9,364,236 | 14.37B |
| 93 | BAX | Baxter International Inc. | 11.79B | -0.96% | 9,968,219 | 11.47B |
| 94 | FMS | Fresenius Medical Care AG | 11.76B | 0.59% | 818,574 | 22.19B |
| 95 | DVA | DaVita Inc. | 11.73B | 0.42% | 2,098,920 | 14.01B |
| 96 | SNN | Smith & Nephew plc | 11.56B | -0.79% | 1,452,748 | 6.30B |
| 97 | TECH | Bio-Techne Corporation | 11.35B | -0.06% | 5,019,527 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.20B | -1.41% | 7,946,789 | 5.02B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 10.88B | -3.03% | 869,321 | 776.57M |
| 100 | COO | The Cooper Companies, Inc. | 10.51B | 2.81% | 8,795,796 | 4.24B |
| 101 | AVTR | Avantor, Inc. | 10.50B | -2.14% | 14,825,243 | 6.56B |
| 102 | ALGN | Align Technology, Inc. | 10.49B | -1.40% | 1,498,331 | 4.14B |
| 103 | TWST | Twist Bioscience Corporation | 10.47B | 7.35% | 3,073,852 | 431.80M |
| 104 | MOH | Molina Healthcare, Inc. | 10.46B | -2.10% | 860,068 | 42.47B |
| 105 | UHS | Universal Health Services, Inc. | 10.41B | -2.25% | 1,796,229 | 18.11B |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.17B | - | 1,894,904 | 3.50B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.06B | -1.57% | 324,347 | 2.59B |
| 108 | ENSG | The Ensign Group, Inc. | 10.05B | -0.58% | 688,466 | 5.49B |
| 109 | RGEN | Repligen Corporation | 9.98B | -0.73% | 1,359,746 | 785.10M |
| 110 | TXG | 10x Genomics, Inc. | 9.98B | -0.48% | 2,887,167 | 616.91M |
| 111 | KRYS | Krystal Biotech, Inc. | 9.97B | -0.61% | 1,003,948 | 440.48M |
| 112 | GMED | Globus Medical, Inc. | 9.95B | -0.11% | 2,904,292 | 3.14B |
| 113 | OSCR | Oscar Health, Inc. | 9.91B | 0.47% | 9,455,548 | 15.32B |
| 114 | KYMR | Kymera Therapeutics, Inc. | 9.79B | -0.62% | 1,900,282 | 105.00M |
| 115 | PODD | Insulet Corporation | 9.75B | -0.67% | 2,506,361 | 3.05B |
| 116 | GKOS | Glaukos Corporation | 9.66B | 1.48% | 1,464,473 | 612.84M |
| 117 | CYTK | Cytokinetics, Incorporated | 9.56B | -1.63% | 4,872,973 | 67.67M |
| 118 | HSIC | Henry Schein, Inc. | 9.46B | -0.24% | 2,220,202 | 13.60B |
| 119 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.39B | -1.86% | 4,016,380 | 669.50M |
| 120 | BRKR | Bruker Corporation | 9.35B | -2.63% | 2,820,376 | 3.50B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.25B | -0.49% | 1,837,204 | 281.99M |
| 122 | ABVX | ABIVAX Société Anonyme | 9.10B | -1.82% | 876,034 | 5.67M |
| 123 | IBRX | ImmunityBio, Inc. | 8.99B | 0.24% | 18,428,898 | 165.79M |
| 124 | QGEN | Qiagen N.V. | 8.96B | -2.37% | 1,748,678 | 2.10B |
| 125 | PCVX | Vaxcyte, Inc. | 8.65B | -3.71% | 2,717,362 | - |
| 126 | CAI | Caris Life Sciences, Inc. | 8.47B | -3.04% | 14,723,094 | 989.61M |
| 127 | PRAX | Praxis Precision Medicines, Inc. | 8.35B | -3.71% | 829,853 | 7.46M |
| 128 | TGTX | TG Therapeutics, Inc. | 8.07B | 0.71% | 5,168,992 | 799.54M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.96B | -2.62% | 3,357,066 | - |
| 130 | ATR | AptarGroup, Inc. | 7.91B | -0.84% | 821,263 | 3.93B |
| 131 | HQY | HealthEquity, Inc. | 7.87B | 0.67% | 1,297,938 | 1.36B |
| 132 | HNGE | Hinge Health, Inc. | 7.66B | 0.19% | 4,866,155 | 720.06M |
| 133 | IMVT | Immunovant, Inc. | 7.63B | -1.86% | 2,943,792 | - |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.39B | -4.94% | 7,369,359 | 874.09M |
| 135 | ALKS | Alkermes plc | 7.28B | -7.11% | 6,935,802 | 1.67B |
| 136 | BLTE | Belite Bio, Inc | 6.88B | 0.36% | 93,895 | - |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.73B | -1.32% | 1,124,806 | 239.92M |
| 138 | PACS | PACS Group, Inc. | 6.67B | 0.14% | 1,196,430 | 5.55B |
| 139 | CGON | CG Oncology, Inc. | 6.61B | -1.32% | 1,779,246 | 6.23M |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.56B | -0.25% | 1,027,912 | 1.56B |
| 141 | CHE | Chemed Corporation | 6.56B | -0.38% | 417,571 | 2.60B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.53B | 0.36% | 9,395,964 | 2.58B |
| 143 | GRFS | Grifols, S.A. | 6.52B | -1.22% | 367,746 | 8.48B |
| 144 | AMRX | Amneal Pharmaceuticals, Inc. | 6.52B | 2.35% | 6,619,091 | 3.12B |
| 145 | ORKA | Oruka Therapeutics, Inc. | 6.29B | -2.83% | 1,943,009 | - |
| 146 | MMED | MiniMed Group, Inc. | 6.13B | -1.09% | 2,881,501 | 3.22B |
| 147 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.03B | -2.63% | 1,058,199 | 840.85M |
| 148 | BLCO | Bausch + Lomb Corporation | 6.02B | 0.48% | 359,135 | 5.32B |
| 149 | LQDA | Liquidia Corporation | 5.99B | -2.21% | 3,896,375 | 450.91M |
| 150 | RDNT | RadNet, Inc. | 5.98B | -2.29% | 1,284,469 | 2.27B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 5.96B | -7.07% | 1,798,008 | 618.07M |
| 152 | STVN | Stevanato Group S.p.A. | 5.93B | -4.28% | 265,546 | 1.40B |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.92B | -3.06% | 2,235,859 | 591.33M |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.68B | -4.83% | 3,253,096 | - |
| 155 | LGND | Ligand Pharmaceuticals Incorporated | 5.65B | -0.43% | 372,802 | 290.54M |
| 156 | CRSP | CRISPR Therapeutics AG | 5.47B | -1.34% | 3,382,855 | 13.39M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.47B | -5.09% | 4,604,077 | - |
| 158 | PTCT | PTC Therapeutics, Inc. | 5.46B | -3.87% | 3,864,990 | 1.01B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.42B | -4.26% | 2,829,352 | 1.90M |
| 160 | SHC | Sotera Health Company | 5.35B | -1.16% | 6,379,984 | 1.22B |
| 161 | TFX | Teleflex Incorporated | 5.28B | -0.85% | 1,800,977 | 2.25B |
| 162 | DFTX | Definium Therapeutics, Inc. | 5.21B | 0.34% | 3,215,201 | - |
| 163 | ERAS | Erasca, Inc. | 5.17B | -3.72% | 8,687,431 | - |
| 164 | PBLS | Parabilis Medicines, Inc. | 5.16B | 2.08% | 9,086,012 | 148.00K |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.10B | -0.23% | 910,444 | 1.58B |
| 166 | BLLN | BillionToOne, Inc. | 5.00B | -4.29% | 1,943,524 | 397.41M |
| 167 | HAE | Haemonetics Corporation | 4.93B | 0.74% | 1,300,443 | 1.35B |
| 168 | EWTX | Edgewise Therapeutics, Inc. | 4.92B | -3.45% | 1,991,954 | - |
| 169 | WAY | Waystar Holding Corp. | 4.92B | -3.21% | 2,820,894 | 1.21B |
| 170 | LFST | LifeStance Health Group, Inc. | 4.80B | -0.32% | 17,910,867 | 1.58B |
| 171 | ACAD | ACADIA Pharmaceuticals Inc. | 4.70B | -0.58% | 5,482,813 | 1.14B |
| 172 | DOCS | Doximity, Inc. | 4.65B | -1.73% | 7,207,251 | 655.57M |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 4.64B | 2.30% | 22,879,705 | 324.97M |
| 174 | ADPT | Adaptive Biotechnologies Corporation | 4.57B | 0.21% | 2,985,539 | 308.08M |
| 175 | CON | Concentra Group Holdings Parent, Inc. | 4.52B | -0.17% | 4,867,077 | 2.29B |
| 176 | MANE | Veradermics, Incorporated | 4.46B | -1.78% | 1,870,224 | - |
| 177 | HTFL | HeartFlow, Inc. | 4.41B | 2.38% | 6,607,228 | 212.07M |
| 178 | LIVN | LivaNova PLC | 4.30B | 0.28% | 1,377,463 | 1.47B |
| 179 | ITGR | Integer Holdings Corporation | 4.29B | -0.04% | 830,922 | 1.84B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.13B | -1.82% | 10,076,060 | 10.35M |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.12B | -2.27% | 4,684,181 | 1.33B |
| 182 | ABCL | AbCellera Biologics Inc. | 4.09B | -0.79% | 5,438,253 | 66.17M |
| 183 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.07B | -4.51% | 2,048,795 | -665.00K |
| 184 | CELC | Celcuity Inc. | 3.94B | -5.06% | 1,406,194 | - |
| 185 | XENE | Xenon Pharmaceuticals Inc. | 3.85B | -30.69% | 17,948,749 | 7.50M |
| 186 | PLSE | Pulse Biosciences, Inc. | 3.84B | 6.44% | 867,540 | 1.19M |
| 187 | ICUI | ICU Medical, Inc. | 3.82B | -0.17% | 388,086 | 2.16B |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.81B | 0.64% | 187,397 | 890.79M |
| 189 | NVST | Envista Holdings Corporation | 3.75B | -1.44% | 5,636,389 | 2.86B |
| 190 | IDYA | IDEAYA Biosciences, Inc. | 3.71B | -0.52% | 2,492,502 | 234.13M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.67B | -7.41% | 6,243,030 | 53.81M |
| 192 | OPCH | Option Care Health, Inc. | 3.64B | -0.82% | 5,680,340 | 5.69B |
| 193 | ELVN | Enliven Therapeutics, Inc. | 3.62B | -1.57% | 6,005,807 | - |
| 194 | GRAL | GRAIL, Inc. | 3.61B | 1.03% | 3,003,825 | 165.26M |
| 195 | IRTC | iRhythm Holdings, Inc. | 3.60B | -2.17% | 690,926 | 825.34M |
| 196 | OGN | Organon & Co. | 3.59B | -0.07% | 4,941,532 | 6.13B |
| 197 | NHC | National HealthCare Corporation | 3.48B | -1.21% | 467,826 | 1.56B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 3.43B | -1.19% | 710,969 | 606.33M |
| 199 | LEGN | Legend Biotech Corporation | 3.41B | 0.17% | 2,937,735 | 1.27B |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.38B | -1.26% | 2,671,391 | - |
| 201 | RCUS | Arcus Biosciences, Inc. | 3.21B | -1.17% | 2,897,087 | 117.00M |
| 202 | VCYT | Veracyte, Inc. | 3.20B | -1.91% | 2,667,766 | 561.90M |
| 203 | DYN | Dyne Therapeutics, Inc. | 3.20B | -5.26% | 4,849,571 | - |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.19B | -4.08% | 19,137,072 | 463.98M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.15B | -2.04% | 2,956,194 | 3.60M |
| 206 | QURE | uniQure N.V. | 3.05B | -0.20% | 2,098,556 | 18.67M |
| 207 | MBX | MBX Biosciences, Inc. | 3.03B | -1.53% | 932,363 | - |
| 208 | WGS | GeneDx Holdings Corp. | 3.02B | -3.67% | 786,139 | 454.43M |
| 209 | CLDX | Celldex Therapeutics, Inc. | 3.00B | -1.90% | 2,081,882 | 158.00K |
| 210 | TMDX | TransMedics Group, Inc. | 3.00B | -0.28% | 1,441,904 | 668.47M |
| 211 | AVAH | Aveanna Healthcare Holdings Inc. | 2.98B | -2.15% | 6,548,263 | 2.60B |
| 212 | ATRC | AtriCure, Inc. | 2.96B | -1.73% | 8,670,313 | 569.62M |
| 213 | ZLAB | Zai Lab Limited | 2.89B | -0.43% | 887,484 | 449.61M |
| 214 | RGC | Regencell Bioscience Holdings Limited | 2.87B | -2.85% | 94,300 | - |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.85B | -0.13% | 3,205,602 | 1.46B |
| 216 | NEOG | Neogen Corporation | 2.83B | 1.33% | 7,443,664 | 870.40M |
| 217 | PGEN | Precigen, Inc. | 2.79B | -1.14% | 9,578,263 | 85.72M |
| 218 | CDNA | CareDx, Inc. | 2.78B | -0.83% | 1,384,015 | 458.09M |
| 219 | WRBY | Warby Parker Inc. | 2.78B | -6.95% | 4,809,934 | 911.61M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.73B | -1.12% | 7,415,026 | 2.93B |
| 221 | IMNM | Immunome, Inc. | 2.72B | 0.17% | 3,962,927 | 4.02M |
| 222 | NAMS | NewAmsterdam Pharma Company N.V. | 2.69B | 2.55% | 2,076,380 | 7.12M |
| 223 | IRON | Disc Medicine, Inc. | 2.67B | 0.51% | 1,077,129 | - |
| 224 | NRIX | Nurix Therapeutics, Inc. | 2.64B | -0.24% | 2,839,522 | 36.77M |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.64B | -1.67% | 2,683,269 | 3.37B |
| 226 | AXGN | Axogen, Inc. | 2.60B | -2.34% | 1,124,697 | 251.17M |
| 227 | NEO | NeoGenomics, Inc. | 2.56B | 0.10% | 4,400,262 | 766.30M |
| 228 | PHVS | Pharvaris N.V. | 2.55B | -4.29% | 580,260 | - |
| 229 | PRVA | Privia Health Group, Inc. | 2.54B | -1.19% | 2,759,488 | 2.36B |
| 230 | GPCR | Structure Therapeutics Inc. | 2.50B | -0.28% | 1,548,033 | - |
| 231 | BEAM | Beam Therapeutics Inc. | 2.49B | 1.13% | 2,288,333 | 156.04M |
| 232 | VRDN | Viridian Therapeutics, Inc. | 2.49B | 0.32% | 5,381,491 | 71.13M |
| 233 | MLYS | Mineralys Therapeutics, Inc. | 2.48B | 0.14% | 3,786,987 | - |
| 234 | HCM | HUTCHMED (China) Limited | 2.46B | -1.09% | 15,795 | 549.12M |
| 235 | VERA | Vera Therapeutics, Inc. | 2.45B | -0.79% | 4,191,151 | - |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.45B | -1.68% | 3,820,525 | 959.90M |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.44B | -2.14% | 1,182,920 | 830.44M |
| 238 | ALMR | Alamar Biosciences, Inc. | 2.42B | 8.87% | 2,027,540 | 100.42M |
| 239 | CLOV | Clover Health Investments, Corp. | 2.37B | -1.76% | 6,174,738 | 2.48B |
| 240 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | -0.35% | 14,607,376 | - |
| 241 | NKTR | Nektar Therapeutics | 2.29B | -1.84% | 2,806,733 | 54.59M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.25B | -0.35% | 1,198,256 | 311.51M |
| 243 | INSP | Inspire Medical Systems, Inc. | 2.22B | 5.55% | 2,127,750 | 898.74M |
| 244 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.22B | -0.23% | 12,746,888 | 940.61M |
| 245 | GENB | Generate Biomedicines, Inc. | 2.20B | 0.12% | 1,404,547 | 26.48M |
| 246 | OCUL | Ocular Therapeutix, Inc. | 2.19B | -1.48% | 4,100,931 | 52.06M |
| 247 | SDGR | Schrödinger, Inc. | 2.17B | -4.03% | 5,231,066 | 259.04M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -2.44% | 646,463 | - |
| 249 | UFPT | UFP Technologies, Inc. | 2.14B | 0.46% | 146,381 | 631.64M |
| 250 | ADUS | Addus HomeCare Corporation | 2.14B | -0.84% | 590,708 | 1.48B |
| 251 | TRLV | Trulieve Cannabis Corp. | 2.13B | -4.98% | 12,704,586 | 1.14B |
| 252 | PBH | Prestige Consumer Healthcare Inc. | 2.13B | -3.23% | 2,020,575 | 1.10B |
| 253 | TRVI | Trevi Therapeutics, Inc. | 2.13B | -1.71% | 2,138,489 | - |
| 254 | SRPT | Sarepta Therapeutics, Inc. | 2.12B | -2.71% | 6,292,415 | 1.97B |
| 255 | BHC | Bausch Health Companies Inc. | 2.12B | 0.35% | 1,912,984 | 10.85B |
| 256 | URGN | UroGen Pharma Ltd. | 2.11B | -1.59% | 703,083 | 188.73M |
| 257 | CMPS | COMPASS Pathways plc | 2.10B | 1.27% | 3,574,304 | - |
| 258 | BFLY | Butterfly Network, Inc. | 2.10B | -1.01% | 5,549,323 | 112.14M |
| 259 | ALVO | Alvotech | 2.10B | 9.93% | 3,535,736 | 494.61M |
| 260 | PGNY | Progyny, Inc. | 2.08B | 0.44% | 3,141,063 | 1.31B |
| 261 | ESTA | Establishment Labs Holdings Inc. | 2.07B | -0.37% | 238,509 | 245.82M |
| 262 | BHVN | Biohaven Ltd. | 2.06B | -1.94% | 6,431,845 | - |
| 263 | MD | Pediatrix Medical Group, Inc. | 2.06B | 1.73% | 2,056,959 | 1.95B |
| 264 | NUVB | Nuvation Bio Inc. | 2.05B | -3.62% | 4,434,811 | 169.90M |
| 265 | RXRX | Recursion Pharmaceuticals, Inc. | 2.05B | 8.19% | 44,325,596 | 54.86M |
| 266 | ZBIO | Zenas BioPharma, Inc. | 2.05B | -1.47% | 2,515,166 | 1.00M |
| 267 | KOD | Kodiak Sciences Inc. | 2.05B | -0.43% | 1,608,965 | - |
| 268 | VCEL | Vericel Corporation | 2.05B | -0.02% | 1,126,476 | 306.30M |
| 269 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.79% | 11,401,495 | 512.28M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | -1.61% | 1,566,179 | 98.34M |
| 271 | MESO | Mesoblast Limited | 1.95B | 1.75% | 215,703 | 120.25M |
| 272 | NVCR | NovoCure Limited | 1.94B | -0.18% | 1,152,698 | 699.19M |
| 273 | RAPP | Rapport Therapeutics, Inc. | 1.94B | -3.58% | 998,059 | 20.00M |
| 274 | GHRS | GH Research PLC | 1.94B | -1.60% | 132,832 | - |
| 275 | COAG | Hemab Therapeutics Holdings, Inc. | 1.92B | -0.07% | 4,149,493 | - |
| 276 | XRAY | DENTSPLY SIRONA Inc. | 1.90B | 1.71% | 8,473,267 | 3.64B |
| 277 | FTRE | Fortrea Holdings Inc. | 1.90B | -1.73% | 3,107,459 | 2.68B |
| 278 | ZYME | Zymeworks Inc. | 1.89B | -3.31% | 1,096,079 | 37.13M |
| 279 | PRGO | Perrigo Company plc | 1.88B | 0.59% | 6,878,268 | 4.14B |
| 280 | BRVE | Braveheart Bio, Inc. | 1.87B | 5.38% | 2,018,533 | - |
| 281 | LKFT | Lakefront Biotherapeutics NV | 1.86B | -1.25% | 459,128 | 1.13B |
| 282 | FRNM | Freenome, Inc. | 1.84B | 5.03% | 6,047,307 | 35.41M |
| 283 | XNCR | Xencor, Inc. | 1.84B | 0.53% | 5,207,448 | 104.97M |
| 284 | STOK | Stoke Therapeutics, Inc. | 1.83B | -1.73% | 1,560,348 | 27.59M |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.81B | -1.21% | 740,770 | 481.07M |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | -4.13% | 2,518,507 | 208.78M |
| 287 | SEPN | Septerna, Inc. | 1.81B | -2.05% | 448,204 | 98.88M |
| 288 | LMAT | LeMaitre Vascular, Inc. | 1.80B | -0.76% | 399,368 | 262.43M |
| 289 | BLFS | BioLife Solutions, Inc. | 1.79B | -0.43% | 1,027,700 | 106.69M |
| 290 | VIR | Vir Biotechnology, Inc. | 1.79B | -2.93% | 7,017,421 | 303.23M |
| 291 | TYRA | Tyra Biosciences, Inc. | 1.77B | 5.32% | 2,069,689 | - |
| 292 | ASTH | Astrana Health, Inc. | 1.76B | 0.17% | 1,438,090 | 3.84B |
| 293 | PSNL | Personalis, Inc. | 1.75B | 1.05% | 3,180,446 | 69.67M |
| 294 | NBTX | Nanobiotix S.A. | 1.74B | -7.89% | 149,345 | 38.27M |
| 295 | ALHC | Alignment Healthcare, Inc. | 1.73B | -4.02% | 23,590,977 | 4.58B |
| 296 | SGRY | Surgery Partners, Inc. | 1.72B | -0.75% | 2,763,761 | 3.37B |
| 297 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -0.98% | 8,626,304 | 59.51M |
| 298 | NVAX | Novavax, Inc. | 1.67B | 1.10% | 11,145,562 | 413.80M |
| 299 | KLRA | Kailera Therapeutics, Inc. | 1.66B | -0.70% | 3,164,418 | - |
| 300 | ABSI | Absci Corporation | 1.66B | 4.10% | 7,732,762 | 1.56M |
| 301 | IMCR | Immunocore Holdings plc | 1.65B | -0.93% | 475,904 | 430.78M |
| 302 | TSHA | Taysha Gene Therapies, Inc. | 1.64B | -2.71% | 9,116,676 | 5.49M |
| 303 | ANAB | AnaptysBio, Inc. | 1.63B | 0.25% | 868,845 | 232.39M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.63B | 0.99% | 1,160,357 | 978.38M |
| 305 | INBX | Inhibrx Biosciences, Inc. | 1.61B | 4.41% | 483,377 | 1.30M |
| 306 | KRSA | Korsana Biosciences, Inc. | 1.59B | 3.77% | 33,892 | - |
| 307 | ETON | Eton Pharmaceuticals, Inc. | 1.59B | -2.75% | 891,703 | 105.60M |
| 308 | SNDX | Syndax Pharmaceuticals, Inc. | 1.57B | -0.34% | 5,181,953 | 252.25M |
| 309 | ATEC | Alphatec Holdings, Inc. | 1.57B | -0.97% | 2,791,491 | 815.05M |
| 310 | KARD | Kardigan, Inc. | 1.56B | -0.30% | 6,566,538 | - |
| 311 | INVA | Innoviva, Inc. | 1.53B | 0.43% | 1,437,042 | 440.00M |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.50B | 0.22% | 934,228 | - |
| 313 | AGL | agilon health, inc. | 1.50B | -0.01% | 370,060 | 5.92B |
| 314 | LTGO | Latigo Biotherapeutics, Inc. | 1.50B | -5.77% | 1,488,236 | - |
| 315 | XERS | Xeris Biopharma Holdings, Inc. | 1.50B | 0.49% | 4,709,393 | 335.41M |
| 316 | INNV | InnovAge Holding Corp. | 1.49B | 2.06% | 331,570 | 989.71M |
| 317 | ARDT | Ardent Health, Inc. | 1.48B | -2.06% | 501,992 | 6.41B |
| 318 | HCSG | Healthcare Services Group, Inc. | 1.47B | -0.09% | 1,533,596 | 1.86B |
| 319 | OMCL | Omnicell, Inc. | 1.47B | -1.20% | 937,250 | 1.25B |
| 320 | AZTA | Azenta, Inc. | 1.46B | -1.16% | 1,430,309 | 613.81M |
| 321 | KMTS | Kestra Medical Technologies, Ltd. | 1.46B | 0.33% | 1,249,225 | 106.73M |
| 322 | NUTX | Nutex Health Inc. | 1.43B | -2.58% | 246,791 | 846.72M |
| 323 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | 0.07% | 13,335,258 | 717.00M |
| 324 | AVBP | ArriVent BioPharma, Inc. | 1.42B | 1.90% | 1,238,533 | - |
| 325 | DRTS | Alpha Tau Medical Ltd. | 1.41B | -1.61% | 624,257 | - |
| 326 | PAHC | Phibro Animal Health Corporation | 1.40B | 0.32% | 635,514 | 1.52B |
| 327 | AVLN | Avalyn Pharma Inc. | 1.40B | -5.71% | 664,783 | - |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.39B | -0.83% | 3,316,844 | - |
| 329 | AAPG | Ascentage Pharma Group International | 1.39B | -2.02% | 2,067 | 94.61M |
| 330 | PNTG | The Pennant Group, Inc. | 1.38B | -1.02% | 799,322 | 1.10B |
| 331 | TRAX | First Tracks Biotherapeutics, Inc. | 1.38B | -1.53% | 2,590,718 | - |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.37B | 0.78% | 531,642 | - |
| 333 | SVRA | Savara Inc. | 1.36B | -0.92% | 2,181,901 | - |
| 334 | CNMD | CONMED Corporation | 1.36B | -1.54% | 780,481 | 1.37B |
| 335 | CGEM | Cullinan Therapeutics, Inc. | 1.36B | -1.31% | 3,251,021 | - |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.33B | -0.84% | 1,073,149 | 3.43B |
| 337 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | -0.70% | 3,090,944 | - |
| 338 | OMER | Omeros Corporation | 1.29B | -3.14% | 2,151,926 | 38.42M |
| 339 | CERT | Certara, Inc. | 1.28B | -1.86% | 6,720,340 | 421.75M |
| 340 | MGTX | MeiraGTx Holdings plc | 1.27B | 1.53% | 941,210 | 397.50M |
| 341 | VOR | Vor Biopharma Inc. | 1.27B | -2.24% | 3,725,699 | - |
| 342 | MAZE | Maze Therapeutics, Inc. | 1.25B | -3.92% | 1,494,820 | 20.00M |
| 343 | OMDA | Omada Health, Inc. | 1.25B | 3.03% | 6,709,684 | 309.76M |
| 344 | OPK | OPKO Health, Inc. | 1.25B | 3.09% | 5,344,201 | 587.90M |
| 345 | HROW | Harrow, Inc. | 1.24B | -0.15% | 1,743,516 | 275.59M |
| 346 | REPL | Replimune Group, Inc. | 1.23B | 1.55% | 2,149,948 | - |
| 347 | USPH | U.S. Physical Therapy, Inc. | 1.23B | -0.73% | 336,795 | 804.27M |
| 348 | CRON | Cronos Group Inc. | 1.23B | -0.59% | 1,070,915 | 179.09M |
| 349 | AKTS | Aktis Oncology, Inc. | 1.22B | -4.29% | 2,729,360 | 10.06M |
| 350 | APMD | Apnimed, Inc. | 1.21B | 3.17% | 3,141,798 | 115.12M |
| 351 | ANRO | Alto Neuroscience, Inc. | 1.19B | -2.29% | 2,199,284 | - |
| 352 | IART | Integra LifeSciences Holdings Corporation | 1.18B | 0.79% | 2,169,063 | 1.65B |
| 353 | IMTX | Immatics N.V. | 1.18B | -2.27% | 759,925 | 47.65M |
| 354 | TNDM | Tandem Diabetes Care, Inc. | 1.17B | -2.09% | 2,284,176 | 1.04B |
| 355 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | 5.00% | 2,604,396 | 99.00K |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.15B | -0.59% | 1,359,896 | 785.23M |
| 357 | BBNX | Beta Bionics, Inc. | 1.15B | 2.15% | 1,529,029 | 119.01M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.15B | -1.97% | 2,178,493 | - |
| 359 | TDOC | Teladoc Health, Inc. | 1.14B | 0.32% | 5,496,368 | 2.49B |
| 360 | AORT | Artivion, Inc. | 1.14B | -2.22% | 1,914,780 | 471.47M |
| 361 | MNKD | MannKind Corporation | 1.14B | -1.12% | 5,513,383 | 393.63M |
| 362 | PRCT | PROCEPT BioRobotics Corporation | 1.11B | -0.87% | 1,491,271 | 337.34M |
| 363 | OBX | Obsidian Therapeutics, Inc. | 1.10B | 1.43% | 3,974,351 | - |
| 364 | BVS | Bioventus Inc. | 1.09B | 2.22% | 828,234 | 581.85M |
| 365 | CSTL | Castle Biosciences, Inc. | 1.08B | -3.92% | 530,243 | 357.28M |
| 366 | JBIO | Jade Biosciences, Inc. | 1.08B | -1.17% | 2,942,225 | - |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.06B | -3.82% | 678,176 | 1.04B |
| 368 | CRVS | Corvus Pharmaceuticals, Inc. | 1.06B | 0.08% | 4,460,676 | - |
| 369 | MLTX | MoonLake Immunotherapeutics | 1.05B | 0.32% | 1,803,353 | - |
| 370 | IRMD | IRADIMED CORPORATION | 1.05B | -0.75% | 211,442 | 86.34M |
| 371 | STAA | STAAR Surgical Company | 1.04B | -1.98% | 5,743,197 | 339.59M |
| 372 | KURA | Kura Oncology, Inc. | 1.04B | 0.09% | 2,665,263 | 77.23M |
| 373 | ENOV | Enovis Corporation | 1.04B | 1.35% | 2,645,397 | 2.30B |
| 374 | GLUE | Monte Rosa Therapeutics, Inc. | 1.03B | -3.73% | 1,598,226 | 28.73M |
| 375 | JANX | Janux Therapeutics, Inc. | 1.01B | -1.60% | 2,447,406 | 24.00M |
| 376 | ANL | Adlai Nortye Group Ltd. | 1.01B | 3.01% | 156,623 | 18.06M |
| 377 | ATTO | Attovia Therapeutics, Inc. | 1.01B | -2.60% | 1,361,382 | 1.80M |
| 378 | ALMS | Alumis Inc. | 1.01B | -0.64% | 6,393,054 | 7.40M |
| 379 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.00B | -0.84% | 1,455,804 | 730.02M |
| 380 | ABUS | Arbutus Biopharma Corporation | 991.22M | -1.18% | 6,458,529 | 181.72M |
| 381 | PCRX | Pacira BioSciences, Inc. | 984.19M | 0.86% | 680,876 | 746.16M |
| 382 | SLBT | SL Science Holding Limited | 980.86M | -8.02% | 60,458 | 3.27M |
| 383 | GMRS | GMR Solutions Inc. | 973.85M | -1.03% | 6,034,069 | 5.88B |
| 384 | SGP | SpyGlass Pharma, Inc. | 972.67M | -0.85% | 613,827 | - |
| 385 | SLDB | Solid Biosciences Inc. | 955.38M | 0.45% | 4,090,598 | - |
| 386 | CBLL | CeriBell, Inc. | 935.27M | -2.52% | 931,886 | 101.96M |
| 387 | SANA | Sana Biotechnology, Inc. | 928.02M | - | 7,408,966 | - |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 912.16M | 0.74% | 7,458,743 | 41.47M |
| 389 | HELP | Cybin Inc. | 903.75M | -11.77% | 5,666,927 | - |
| 390 | HSTM | HealthStream, Inc. | 894.32M | 0.14% | 413,197 | 321.12M |
| 391 | IMMX | Immix Biopharma, Inc. | 894.24M | -1.73% | 4,183,929 | - |
| 392 | FTH | Faeth Therapeutics, Inc. | 891.49M | -1.79% | 2,197,797 | - |
| 393 | AVTX | Avalo Therapeutics, Inc. | 888.65M | -0.72% | 3,233,382 | 59.00K |
| 394 | TBPH | Theravance Biopharma, Inc. | 883.66M | -0.12% | 683,740 | 104.31M |
| 395 | IVA | Inventiva S.A. | 875.21M | 0.80% | 1,045,553 | 7.94M |
| 396 | RIGL | Rigel Pharmaceuticals, Inc. | 871.23M | 1.72% | 939,570 | 276.79M |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 859.23M | -0.81% | 3,061,451 | - |
| 398 | WVE | Wave Life Sciences, Inc. | 857.16M | -2.03% | 4,410,599 | 65.37M |
| 399 | ARDX | Ardelyx, Inc. | 852.22M | 1.18% | 6,443,092 | 450.89M |
| 400 | FDMT | 4D Molecular Therapeutics, Inc. | 840.82M | 3.68% | 1,787,707 | 92.01M |
| 401 | GERN | Geron Corporation | 835.22M | -1.52% | 17,244,691 | 204.56M |
| 402 | ETRA | Electra Therapeutics, Inc. | 831.66M | -11.67% | 5,124,319 | - |
| 403 | CADL | Candel Therapeutics, Inc. | 830.23M | -4.32% | 3,014,534 | - |
| 404 | INMD | InMode Ltd. | 824.85M | -1.31% | 758,086 | 374.63M |
| 405 | ACHV | Achieve Life Sciences, Inc. | 821.16M | 0.88% | 2,830,275 | - |
| 406 | SIBN | SI-BONE, Inc. | 810.77M | 0.28% | 861,414 | 213.60M |
| 407 | ACRS | Aclaris Therapeutics, Inc. | 809.59M | 1.85% | 4,688,000 | 8.22M |
| 408 | CLYM | Climb Bio, Inc. | 806.98M | -0.07% | 4,049,712 | - |
| 409 | ANNX | Annexon, Inc. | 801.92M | 1.44% | 4,940,248 | - |
| 410 | GYRE | Gyre Therapeutics, Inc. | 800.55M | 5.15% | 1,203,860 | 109.82M |
| 411 | AVR | Anteris Technologies Global Corp. | 795.26M | -3.09% | 1,809,059 | 2.24M |
| 412 | BLSM | BlossomHill Therapeutics, Inc. | 788.77M | -4.03% | 715,113 | - |
| 413 | VREX | Varex Imaging Corporation | 779.32M | -0.27% | 834,416 | 865.00M |
| 414 | DSGN | Design Therapeutics, Inc. | 766.00M | -4.45% | 2,554,960 | - |
| 415 | AHCO | AdaptHealth Corp. | 761.77M | -0.87% | 4,977,191 | 3.36B |
| 416 | GLAS | Glass House Brands Inc. | 751.11M | -0.25% | 881,501 | 176.98M |
| 417 | PHAR | Pharming Group N.V. | 744.14M | -2.13% | 7,853 | 366.48M |
| 418 | COLL | Collegium Pharmaceutical, Inc. | 741.29M | 1.74% | 1,992,651 | 808.21M |
| 419 | SLN | Silence Therapeutics plc | 734.55M | -3.94% | 1,142,412 | 615.00K |
| 420 | DBVT | DBV Technologies S.A. | 729.61M | -1.28% | 137,641 | 5.04M |
| 421 | QDEL | QuidelOrtho Corporation | 728.27M | -4.24% | 2,978,699 | 2.67B |
| 422 | CBIO | Crescent Biopharma, Inc. | 722.91M | 0.72% | 3,123,508 | 11.88M |
| 423 | IRWD | Ironwood Pharmaceuticals, Inc. | 720.45M | 3.07% | 7,691,287 | 389.32M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 716.79M | 2.90% | 880,123 | - |
| 425 | STLN | Starling Oncology, Inc. | 709.34M | 4.98% | 3,761,728 | 587.24M |
| 426 | SOPH | SOPHiA GENETICS SA | 697.20M | -3.99% | 965,128 | 86.17M |
| 427 | MDXG | MiMedx Group, Inc. | 695.28M | 1.71% | 3,904,801 | 355.17M |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 689.45M | -1.94% | 1,481,695 | 136.07M |
| 429 | SGMT | Sagimet Biosciences Inc. | 689.34M | -0.72% | 1,854,066 | - |
| 430 | CTKB | Cytek Biosciences, Inc. | 688.91M | 1.73% | 2,085,868 | 206.71M |
| 431 | VSTM | Verastem, Inc. | 673.79M | -1.46% | 4,497,074 | 87.53M |
| 432 | AURA | Aura Biosciences, Inc. | 667.86M | -2.28% | 3,776,735 | - |
| 433 | SSII | SS Innovations International, Inc. | 653.26M | - | 75,886 | 52.40M |
| 434 | OABI | OmniAb, Inc. | 649.90M | 0.68% | 1,862,359 | 38.46M |
| 435 | MNPR | Monopar Therapeutics Inc. | 647.52M | -6.07% | 382,776 | - |
| 436 | AHG | Akso Health Group | 643.64M | 0.17% | 8,817 | 13.83M |
| 437 | NGNE | Neurogene Inc. | 642.17M | -0.99% | 1,388,880 | 925.00K |
| 438 | ANGO | AngioDynamics, Inc. | 638.17M | 0.46% | 1,012,598 | 320.17M |
| 439 | ALT | Altimmune, Inc. | 632.18M | 0.31% | 12,176,851 | 31.00K |
| 440 | OCS | Oculis Holding AG | 625.96M | 1.60% | 412,068 | 1.45M |
| 441 | SCTX | Scribe Therapeutics Inc. | 624.75M | 2.68% | 2,236,425 | 33.30M |
| 442 | PHR | Phreesia, Inc. | 623.19M | -2.33% | 1,692,437 | 507.79M |
| 443 | VALN | Valneva SE | 608.96M | -0.15% | 42,214 | 163.30M |
| 444 | MPLT | MapLight Therapeutics, Inc. | 606.89M | -3.53% | 1,832,887 | - |
| 445 | STTK | Shattuck Labs, Inc. | 603.18M | 2.74% | 7,400,091 | 1.00M |
| 446 | DRUG | Bright Minds Biosciences Inc. | 602.76M | -0.93% | 142,387 | - |
| 447 | CRMD | CorMedix Inc. | 601.73M | -0.90% | 1,806,489 | 462.25M |
| 448 | CTMX | CytomX Therapeutics, Inc. | 601.40M | -2.13% | 9,598,348 | 18.30M |
| 449 | AGMB | AgomAb Therapeutics NV | 599.35M | 0.75% | 250,674 | - |
| 450 | FLGT | Fulgent Genetics, Inc. | 596.81M | -0.73% | 669,190 | 323.93M |
| 451 | PHAT | Phathom Pharmaceuticals, Inc. | 594.14M | -3.48% | 1,788,579 | 239.66M |
| 452 | EVO | Evotec SE | 593.99M | -4.19% | 1,378,544 | 819.47M |
| 453 | ALLO | Allogene Therapeutics, Inc. | 583.88M | -2.31% | 12,716,961 | 4.64M |
| 454 | WEAV | Weave Communications, Inc. | 583.19M | -0.55% | 3,327,835 | 257.79M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 578.61M | -1.07% | 3,509,333 | 54.09M |
| 456 | PROK | ProKidney Corp. | 577.44M | 6.11% | 9,450,911 | 818.00K |
| 457 | KIDS | OrthoPediatrics Corp. | 569.72M | 0.18% | 320,995 | 252.72M |
| 458 | EPRX | Eupraxia Pharmaceuticals Inc. | 563.16M | 2.39% | 555,036 | - |
| 459 | DCTH | Delcath Systems, Inc. | 559.00M | -0.86% | 703,196 | 95.42M |
| 460 | PRME | Prime Medicine, Inc. | 555.06M | -0.64% | 4,672,909 | 4.07M |
| 461 | TLRY | Tilray Brands, Inc. | 546.60M | 1.27% | 3,134,642 | 915.45M |
| 462 | BWAY | BrainsWay Ltd. | 543.39M | 0.59% | 47,197 | 60.70M |
| 463 | ARVN | Arvinas, Inc. | 542.05M | -0.24% | 1,775,941 | 316.70M |
| 464 | CERS | Cerus Corporation | 534.04M | -0.38% | 3,570,323 | 221.55M |
| 465 | DNA | Ginkgo Bioworks Holdings, Inc. | 530.64M | 0.51% | 1,763,194 | 132.42M |
| 466 | RGNX | REGENXBIO Inc. | 530.09M | -2.31% | 3,375,140 | 174.48M |
| 467 | TECX | Tectonic Therapeutic, Inc. | 527.83M | -0.77% | 330,588 | - |
| 468 | CAPR | Capricor Therapeutics, Inc. | 526.74M | -3.82% | 3,255,709 | 11.13M |
| 469 | OVID | Ovid Therapeutics Inc. | 525.35M | -0.37% | 5,899,316 | 1.58M |
| 470 | CTEV | Claritev Corporation | 522.15M | -2.90% | 305,220 | 994.67M |
| 471 | EOLS | Evolus, Inc. | 519.16M | -1.87% | 1,181,609 | 316.49M |
| 472 | AUTL | Autolus Therapeutics plc | 516.36M | 1.04% | 1,769,812 | 117.39M |
| 473 | ENTX | Entera Bio Ltd. | 512.50M | -2.31% | 288,976 | 42.00K |
| 474 | CTNM | Contineum Therapeutics, Inc. | 509.01M | 2.42% | 2,139,451 | - |
| 475 | ASMB | Assembly Biosciences, Inc. | 508.40M | -1.46% | 1,413,894 | 74.85M |
| 476 | SENS | Senseonics Holdings, Inc. | 506.53M | 1.59% | 1,723,692 | 48.55M |
| 477 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 478 | TCMD | Tactile Systems Technology, Inc. | 502.88M | -1.60% | 443,891 | 350.31M |
| 479 | PRLD | Prelude Therapeutics Incorporated | 501.59M | 6.56% | 1,165,143 | 22.42M |
| 480 | KMDA | Kamada Ltd. | 501.36M | 2.08% | 178,120 | 191.85M |
| 481 | PBYI | Puma Biotechnology, Inc. | 495.55M | 0.84% | 327,066 | 231.24M |
| 482 | NPCE | NeuroPace, Inc. | 490.15M | 0.92% | 235,655 | 106.99M |
| 483 | EIKN | Eikon Therapeutics, Inc. | 484.78M | 4.07% | 2,242,515 | - |
| 484 | VOGX | Vogenx, Inc. | 482.79M | -4.78% | 507,474 | - |
| 485 | INDP | Indaptus Therapeutics, Inc. | 473.01M | -9.67% | 1,163,500 | - |
| 486 | SRTA | Strata Critical Medical, Inc. | 472.41M | -0.74% | 896,495 | 255.98M |
| 487 | ARCT | Arcturus Therapeutics Holdings Inc. | 455.62M | -5.32% | 841,474 | 29.37M |
| 488 | NRC | NRC Health | 454.78M | -1.49% | 360,432 | 140.00M |
| 489 | TTRX | Turn Therapeutics Inc. | 445.03M | 8.10% | 929,982 | - |
| 490 | SGHT | Sight Sciences, Inc. | 441.81M | -0.74% | 453,199 | 83.38M |
| 491 | KYTX | Kyverna Therapeutics, Inc. | 440.94M | 1.28% | 961,255 | - |
| 492 | PRTA | Prothena Corporation plc | 440.47M | 1.42% | 1,830,892 | 54.53M |
| 493 | RLMD | Relmada Therapeutics, Inc. | 439.48M | -1.90% | 2,069,830 | - |
| 494 | MASS | 908 Devices Inc. | 435.24M | -4.10% | 854,920 | 60.84M |
| 495 | CABA | Cabaletta Bio, Inc. | 432.34M | -1.16% | 12,484,814 | - |
| 496 | IRD | Opus Genetics, Inc. | 430.95M | -1.89% | 5,543,230 | 9.86M |
| 497 | AVIR | Atea Pharmaceuticals, Inc. | 427.49M | 1.33% | 600,437 | - |
| 498 | ZURA | Zura Bio Limited | 427.40M | -2.41% | 1,661,807 | - |
| 499 | PACB | Pacific Biosciences of California, Inc. | 425.84M | -0.72% | 4,959,562 | 159.27M |
| 500 | CARL | Carlsmed, Inc. | 425.38M | 1.23% | 238,368 | 63.30M |